Study: Breast Cancer Treated with CDK Inhibitors Not at Increased Risk of Thromboembolic Events
A recent study has evaluated the incidence of thromboembolic events (TEE) in patients diagnosed with advanced HR-positive, HER2-negative breast cancer. Specifically, researchers were concerned that treatment with cyclin dependent kinase…
Continue Reading
Study: Breast Cancer Treated with CDK Inhibitors Not at Increased Risk of Thromboembolic Events
